Sharon S Keene

US Patent:

7481820, Jan 27, 2009

Filed:

May 24, 2004

Appl. No.:

10/852250

Inventors:

Sharon Keene - Tucson AZ, US

International Classification:

A61B 17/34

US Classification:

606187

Abstract:

A tissue graft holder comprising a tray having a plurality of compartments for supporting tissue grafts and a hydrating solution, a channel connecting each compartment to an edge of the tray. The tray is rotatably mounted to a support which in turn is adapted for attachment to an appendage of a user. A dissecting cutting board to accommodate the graft trays and maintain tissue hydration during graft dissection.

US Patent:

20090233954, Sep 17, 2009

Filed:

Aug 29, 2008

Appl. No.:

12/202080

Inventors:

Andy Ofer GOREN - Newport Beach CA, US
Sharon Keene - Tucson AZ, US

International Classification:

A61K 31/435
C12Q 1/68

US Classification:

514284, 435 6

Abstract:

Methods and systems are described for prediction of a patient's response to a drug for treating androgenetic skin disorders such as alopecia, acne, and hirsutism. For a given drug such as anti-androgens and 5-alpha-reductase inhibitors, and a given dosage, the likely responsiveness of that drug and dosage may be determined, for example, by generating a set of patient scores based on a patient profile, including genetic sample information, and comparing that scores to a set of reference information.

US Patent:

20120232045, Sep 13, 2012

Filed:

May 21, 2012

Appl. No.:

13/476793

Inventors:

Andy Ofer Goren - Newport Beach CA, US
Sharon Keene - Tucson AZ, US

International Classification:

C12Q 1/68
A61K 31/585
G06F 15/18
A61P 17/14
A61P 17/10
C40B 30/04
A61P 17/00

US Classification:

514173, 435 611, 506 9, 706 21

Abstract:

Methods and systems are described for prediction of a patient's response to a drug for treating androgenetic skin disorders such as alopecia, acne, and hirsutism. For a given drug such as anti-androgens and 5-alpha-reductase inhibitors, and a given dosage, the likely responsiveness of that drug and dosage may be determined, for example, by generating a set of patient scores based on a patient profile, including genetic sample information, and comparing that scores to a set of reference information.

US Patent:

20220220558, Jul 14, 2022

Filed:

Sep 30, 2021

Appl. No.:

17/491134

Inventors:

Andy Ofer Goren - Newport Beach CA, US
Sharon Keene - Tucson AZ, US

International Classification:

C12Q 1/6883

Abstract:

Methods and systems are described for prediction of a patient's response to a drug for treating androgenetic skin disorders such as alopecia, acne, and hirsutism. For a given drug such as anti-androgens and 5-alpha-reductase inhibitors, and a given dosage, the likely responsiveness of that drug and dosage may be determined, for example, by generating a set of patient scores based on a patient profile, including genetic sample information, and comparing that scores to a set of reference information.

US Patent:

20210298391, Sep 30, 2021

Filed:

Feb 5, 2021

Appl. No.:

17/169253

Inventors:

Sharon A. Keene - Tucson AZ, US
Benjamin J. Davenport - Chaparral NM, US

International Classification:

A41D 13/11
A61L 2/10

Abstract:

A self-sterilizing, face mask, respirator, open or enclosed face shield employs germicidal, far UV-C light safe for direct human exposure, mitigating risk of acquisition or transmission of respiratory pathogens, such as COVID 19. Device attachments or special lenses direct far UV-C light into the respiratory chamber and/or reservoir areas of infection including nasal, oropharyngeal or ocular areas to reduce or eliminate pathogens, serving also as a treatment modality. In a preferred embodiment the face shield has a removable front section, which can be exchanged or replaced with sections that include various functional attributes while maintaining germicidal protections and avoiding need to remove PPE during these activities including consumption of liquids, oral medications or food, as well as providing antimicrobial absorbent sneeze or cough guard or rhinorrhea secretion absorption, or a communication device to address communication deficiencies caused by respiratory protection barriers.